title: Cutaneous Lichenoid dermatitis associated with imatinib mesylate.
authors.forename: Chung-Yin Stanley
authors.initials: CY
authors.lastname: Chan
authors.forename: John
authors.initials: J
authors.lastname: Browning
authors.forename: Megan J
authors.initials: MJ
authors.lastname: Smith-Zagone
authors.forename: Paul T
authors.initials: PT
authors.lastname: Martinelli
authors.forename: Sylvia
authors.initials: S
authors.lastname: Hsu
mesh_terms: D001549:Benzamides; D001707:Biopsy, Needle; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006801:Humans; D000068877:Imatinib Mesylate; D007150:Immunohistochemistry; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000188:drug therapy*; D017512:Lichenoid Eruptions / Q000139:chemically induced* / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use; D018570:Risk Assessment
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate